{"entity":{"type":"insider","cik":"0001876688","url":"/insider/0001876688","json_url":"/insider/0001876688.json","name":"Deerfield Mgmt V, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2021-10-28","last":"2024-09-17","span_basis":"filed_date"},"name_variants":[{"name":"Deerfield Mgmt V, L.P.","source":"filing","n_filings":3,"first_seen":"2021-10-28","last_seen":"2024-09-17"}],"transactions":[{"id":3170001,"accession":"0001193805-24-001131","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-24-001131","line_url":"/filing/0001193805-24-001131","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund V, L.P.; Deerfield Mgmt V, L.P.; Deerfield Mgmt L.P.; Flynn James E","owner_display_name":"DEERFIELD PARTNERS, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":1260000.0,"total_display":"1,260,000.00","total_whole":"1,260,000","shares_owned_after":897587.0,"shares_owned_after_display":"897,587","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-17","scope":"insider","n_lines":2},{"id":6271569,"accession":"0001193805-22-000766","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-22-000766","line_url":"/filing/0001193805-22-000766","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"PepGen Inc.","issuer_ticker":"PEPG","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt V, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund V, L.P.; Deerfield Mgmt L.P.","owner_display_name":"DEERFIELD PARTNERS, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":416666.0,"shares_display":"416,666","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4999992.0,"total_display":"4,999,992.00","total_whole":"4,999,992","shares_owned_after":476813.0,"shares_owned_after_display":"476,813","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-10","filed_date":"2022-05-10","scope":"insider","n_lines":2},{"id":5512444,"accession":"0001193805-21-001508","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-21-001508","line_url":"/filing/0001193805-21-001508","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Xilio Therapeutics, Inc.","issuer_ticker":"XLO","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Mgmt V, L.P.; Deerfield Mgmt L.P.","owner_display_name":"Flynn James E","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":775000.0,"shares_display":"775,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":12400000.0,"total_display":"12,400,000.00","total_whole":"12,400,000","shares_owned_after":1143972.0,"shares_owned_after_display":"1,143,972","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002023658","name":"Bicara Therapeutics Inc.","url":"/issuer/0002023658","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2024-09-17","last_seen":"2024-09-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001835597","name":"PepGen Inc.","url":"/issuer/0001835597","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2022-05-10","last_seen":"2022-05-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001840233","name":"Xilio Therapeutics, Inc.","url":"/issuer/0001840233","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2021-10-28","last_seen":"2021-10-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001876688","retrieved_at":"2026-08-24T08:27:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}